Beneficial effects of tropical fruit-derived polyphenols against lipid-mediated stress in vitro.
Fatty liver formation is a consequence of hyperlipidemia, associated with an imbalance between lipid uptake and its metabolism. Persistent lipid load in the liver cells results in lipid-mediated toxicity or lipotoxicity which leads to the pathogenesis of several metabolic diseases. Recent studies suggest that activation of autophagic pathway might be useful to remove excess hepatic fat. Dietary polyphenols present in fresh fruits and vegetables are able to induce autophagy apart from their well-known anti-oxidative property. Our preliminary observation suggests that fruit-derived polyphenols might be effective to prevent hepatic fat accumulation by inducing autophagy. Total phenolic contents from dragon fruit and mangosteen have been used to address the beneficial properties of these two tropical fruits. Results showed that these polyphenols protect cells against lipotoxicity and oxidative stress. Expression levels of several key genes that are involved in lipid metabolism and energy expenditure were upregulated in presence of these polyphenols. This preliminary study suggests that the underutilized tropical fruits might be useful to develop functional foods, especially those containing beneficial phenolics.
Ignat, I., I. Volf, and V.I. Popa, A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables. Food Chem, 2011. 126(4): p. 1821-35.
Pandey, K.B. and S.I. Rizvi, Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev, 2009. 2(5): p. 270-8.
Tabak, C., et al., Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study). Clin Exp Allergy, 2001. 31(5): p. 747-55.
Bao, M.J., et al., Apple polyphenol protects against cigarette smoke-induced acute lung injury. Nutrition, 2013. 29(1): p. 235-43.
Puel, C., et al., Prevention of bone loss by phloridzin, an apple polyphenol, in ovariectomized rats under inflammation conditions. Calcif Tissue Int, 2005. 77(5): p. 311-8.
Nakajima, D., et al., Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats. J Physiol Anthropol Appl Human Sci, 2001. 20(5): p. 285-91.
Uysal, U., et al., Consumption of polyphenol plants may slow aging and associated diseases. Curr Pharm Des, 2013. 19(34): p. 6094-111.
Fernandez, A.F. and M.F. Fraga, The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics, 2011. 6(7): p. 870-4.
Reinisalo, M., et al., Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases. Oxid Med Cell Longev, 2015. 2015: p. 340520.
Nadim, M., et al., Improvement of polyphenol properties upon glucosylation in a UV-induced skin cell ageing model. Int J Cosmet Sci, 2014. 36(6): p. 579-87.
Chen, Y.K., et al., Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem, 2011. 59(21): p. 11862-71.
Bose, M., et al., The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr, 2008. 138(9): p. 1677-83.
Gan, L., et al., Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Acta Pharmacol Sin, 2015. 36(5): p. 597-605.
Renaud, S. and M. de Lorgeril, Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 1992. 339(8808): p. 1523-6.
Mellor, D.D., et al., High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial. Diabet Med, 2013. 30(4): p. 478-83.
Palma-Duran, S.A., et al., Nutritional Intervention and Impact of Polyphenol on Glycohaemoglobin (HbA1c) in Non-diabetic and Type 2 Diabetic Subjects: Systematic Review and Meta-analysis. Crit Rev Food Sci Nutr, 2015: p. 0.
Thompson, L.U., et al., Relationship between polyphenol intake and blood glucose response of normal and diabetic individuals. Am J Clin Nutr, 1984. 39(5): p. 745-51.
Roseman, H.M., Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. J Manag Care Pharm, 2005. 11(6 Suppl B): p. S3-11.
Sivitz, W.I., Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001. 109(4): p. 55-9, 63-4.
Brons, C. and A. Vaag, Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes. J Physiol, 2009. 587(Pt 16): p. 3977-8.
Lemasters, J.J., et al., The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta, 1998. 1366(1-2): p. 177-96.
Wu, J.J., et al., Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging (Albany NY), 2009. 1(4): p. 425-37.
Pallet, N., D. Anglicheau, and E. Thervet, Autophagy is an adaptative mechanism against endoplasmic reticulum stress. Nephrol Dial Transplant, 2009. 24(12): p. 3891; author reply 3891.
Fu, J., et al., Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro Oncol, 2010. 12(4): p. 328-40.
Qu, X., et al., Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell, 2007. 128(5): p. 931-46.
Yue, Z., et al., Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A, 2003. 100(25): p. 15077-82.
Weidberg, H., E. Shvets, and Z. Elazar, Lipophagy: selective catabolism designed for lipids. Dev Cell, 2009. 16(5): p. 628-30.
Wang, C.W., Lipid droplets, lipophagy, and beyond. Biochim Biophys Acta, 2015.
Sinha, R.A., et al., Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest, 2012. 122(7): p. 2428-38.
Singletary, K. and J. Milner, Diet, autophagy, and cancer: a review. Cancer Epidemiol Biomarkers Prev, 2008. 17(7): p. 1596-610.
Sinha, R.A., et al., Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology, 2014. 59(4): p. 1366-80.
Chen, S., et al., Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta, 2010. 1806(2): p. 220-9.
Sarkar, S., Chemical screening platforms for autophagy drug discovery to identify therapeutic candidates for Huntington's disease and other neurodegenerative disorders. Drug Discov Today Technol, 2013. 10(1): p. e137-44.
Levine, B., M. Packer, and P. Codogno, Development of autophagy inducers in clinical medicine. J Clin Invest, 2015. 125(1): p. 14-24.
Cherniack, E.P., Polyphenols: planting the seeds of treatment for the metabolic syndrome. Nutrition, 2011. 27(6): p. 617-23.
Radad, K., W.D. Rausch, and G. Gille, Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int, 2006. 49(4): p. 379-86.
Singh, R., et al., Autophagy regulates lipid metabolism. Nature, 2009. 458(7242): p. 1131-5.
Liu, K. and M.J. Czaja, Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ, 2013. 20(1): p. 3-11.
Mahattanatawee, K., et al., Total antioxidant activity and fiber content of select Florida-grown tropical fruits. J Agric Food Chem, 2006. 54(19): p. 7355-63.
Lin, T.K., et al., Mitochondrial dysfunction and oxidative stress promote apoptotic cell death in the striatum via cytochrome c/caspase-3 signaling cascade following chronic rotenone intoxication in rats. Int J Mol Sci, 2012. 13(7): p. 8722-39.
Seo, Y.K., et al., Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy. Cell Metab, 2011. 13(4): p. 367-75.
Horton, J.D., J.L. Goldstein, and M.S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 2002. 109(9): p. 1125-31.
Rousset, S., et al., The biology of mitochondrial uncoupling proteins. Diabetes, 2004. 53 Suppl 1: p. S130-5.